[Update carotid artery stenosis]

K Halbritter1, N Weiss

  • 1UniversitätsGefässCentrum und Medizinische Klinik III, Bereich Angiologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland.

Der Internist
|May 17, 2013
PubMed

Insights

Extracranial carotid artery stenosis, a stroke cause, is managed with risk factor control and antiplatelet drugs. Revascularization is key for symptomatic stenosis, while asymptomatic cases often benefit from conservative treatment.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Cardiology

Background:

  • Extracranial carotid artery stenosis is a significant, treatable cause of ischemic stroke.
  • Vascular ultrasound reliably detects and grades carotid artery stenosis.
  • Therapeutic decisions depend on stenosis severity, symptoms, surgical risk, and life expectancy.

Purpose of the Study:

  • To outline current therapeutic strategies for extracranial carotid artery stenosis.
  • To differentiate treatment approaches for symptomatic versus asymptomatic stenosis.
  • To review the roles of conservative management, carotid endarterectomy, and endovascular therapy.

Main Methods:

  • Literature review of diagnostic and therapeutic modalities for carotid artery stenosis.
  • Analysis of treatment guidelines for symptomatic and asymptomatic carotid artery stenosis.
  • Evaluation of outcomes for carotid endarterectomy and endovascular stenting.

Main Results:

  • Optimal medical management includes risk factor control and antiplatelet therapy.
  • Carotid endarterectomy is effective for high-grade symptomatic stenosis.
  • Endovascular therapy offers an alternative for high-risk patients with low complication rates in experienced centers.
  • Asymptomatic stenosis is primarily managed conservatively; revascularization is considered for select low-risk patients.

Conclusions:

  • Treatment of extracranial carotid artery stenosis requires individualized risk assessment.
  • Both surgical and endovascular revascularization are effective stroke prevention strategies in selected patients.
  • Conservative management remains the cornerstone for asymptomatic carotid artery stenosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...